SPAGNOLO, FRANCESCO
SPAGNOLO, FRANCESCO
100010 - Dipartimento di Scienze chirurgiche e diagnostiche integrate
Activity and safety of first-line treatments for advanced melanoma: A network meta-analysis
2023-01-01 Boutros, Andrea; Tanda, Enrica Teresa; Croce, Elena; Catalano, Fabio; Ceppi, Marcello; Bruzzone, Marco; Cecchi, Federica; Arecco, Luca; Fraguglia, Matteo; Pronzato, Paolo; Genova, Carlo; Del Mastro, Lucia; Lambertini, Matteo; Spagnolo, Francesco
ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion
2014-01-01 Gangemi, R; Amaro, A; Gino, A; Barisione, G; Fabbi, M; Pfeffer, U; Brizzolara, A; Queirolo, P; Salvi, S; Boccardo, S; Gualco, M; Spagnolo, F; Jager, Mj; Mosci, C; Rossello, A; Ferrini, S
Adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma: Health-related quality of life from the randomized phase 3 KEYNOTE-716 study
2022-01-01 Khattak, M. A.; Luke, J. J.; Long, G. V.; Ascierto, P. A.; Rutkowski, P.; Schadendorf, D.; Robert, C.; Grob, J. -J.; de la Cruz Merino, L.; Del Vecchio, M.; Spagnolo, F.; Mackiewicz, J.; Chiarion-Sileni, V.; Carlino, M. S.; Mohr, P.; De Galitiis, F.; Ross, M. I.; Eroglu, Z.; Chen, K.; Jiang, R.; Fukunaga-Kalabis, M.; Krepler, C.; Eggermont, A. M. M.; Kirkwood, J. M.
Anastrozole-Induced Carpal Tunnel Syndrome: Results From the International Breast Cancer Intervention Study II Prevention Trial
2016-01-01 Spagnolo, F; Sestak, I; Howell, A; Forbes, Jf; Cuzick, J
Association between PD-1 single nucleotide gene variants and the risk of metastatic melanoma
2024-01-01 Boutros, A.; Carosio, R.; Campanella, D.; Banelli, B.; Morabito, A.; Pistillo, M. P.; Croce, E.; Queirolo, P.; Tanda, E. T.; Raposio, E.; Fontana, V.; Spagnolo, F.
Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study
2017-01-01 Queirolo, P.; Dozin, B.; Morabito, A.; Banelli, B.; Piccioli, P.; Fava, C.; Leo, C.; Carosio, R.; Laurent, S.; Fontana, V.; Ferrucci, P. F.; Martinoli, C.; Cocorocchio, E.; Battaglia, A.; Ascierto, P. A.; Capone, M.; Simeone, E.; De Galitiis, F.; Pagani, E.; Cappellini, G. C. A.; Marchetti, P.; Guida, M.; Tommasi, S.; Mandala, M.; Merelli, B.; Quaglino, P.; Fava, P.; Guidoboni, M.; Romani, M.; Spagnolo, F.; Pistillo, M. P.
Association of vacuum-assisted closure and platelet gel for the definitive surgical repair of an enterocutaneous fistula: a case report.
2012-01-01 Scala, M; Spagnolo, F; Trapasso, Maria; Strada, P; Moresco, Luciano; Santi, Pierluigi
Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma
2022-01-01 Pastorino, Lorenza; Dalmasso, Bruna; Allavena, Eleonora; Vanni, Irene; Ugolini, Filippo; Baroni, Gianna; Croce, Michela; Guadagno, Antonio; Cabiddu, Francesco; Andreotti, Virginia; Bruno, William; Zoppoli, Gabriele; Ferrando, Lorenzo; Tanda, ENRICA TERESA; Spagnolo, Francesco; Menin, Chiara; Gangemi, Rosaria; Massi, Daniela; Ghiorzo, Paola
Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study
2023-01-01 Dummer, R.; Queirolo, P.; Gerard Duhard, P.; Hu, Y.; Wang, D.; de Azevedo, S. J.; Robert, C.; Ascierto, P. A.; Chiarion-Sileni, V.; Pronzato, P.; Spagnolo, F.; Mujika Eizmendi, K.; Liszkay, G.; de la Cruz Merino, L.; Tawbi, H.
Atypical responses in patients with advanced melanoma, lung cancer, renal-cell carcinoma and other solid tumors treated with anti-PD-1 drugs: A systematic review
2017-01-01 Queirolo, P.; Spagnolo, F.
Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma
2022-01-01 Guida, M.; Bartolomeo, N.; Quaresmini, D.; Quaglino, P.; Madonna, G.; Pigozzo, J.; Di Giacomo, A. M.; Minisini, A. M.; Tucci, M.; Spagnolo, F.; Occelli, M.; Ridolfi, L.; Queirolo, P.; De Risi, I.; Valente, M.; Sciacovelli, A. M.; Chiarion Sileni, V.; Ascierto, P. A.; Stigliano, L.; Strippoli, S.
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab
2016-01-01 Ferrucci, Pf; Ascierto, Pa; Pigozzo, J; Del Vecchio, M; Maio, M; Cappellini, Gca; Guidoboni, M; Queirolo, P; Savoia, P; Mandala, M; Simeone, E; Valpione, S; Altomonte, M; Spagnolo, F; Cocorocchio, E; Gandini, S; Giannarelli, D; Martinoli, C
Binimetinib for the treatment of NRAS-mutant melanoma
2017-01-01 Queirolo, P.; Spagnolo, F.
BRAF plus MEK-targeted drugs: a new standard of treatment for BRAF-mutant advanced melanoma
2017-01-01 Queirolo, P; Spagnolo, F
BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies.
2015-01-01 Spagnolo, Francesco; Ghiorzo, Paola; Orgiano, L; Pastorino, Lorenza; Picasso, V; Tornari, Elena; Ottaviano, V; Queirolo, P.
Case Report: Immune-Related Toxicity During Adjuvant Treatment With BRAF Plus MEK Inhibitors in a Melanoma Patient
2020-01-01 Boutros, A.; Schiavi, C.; Cecchi, F.; Spagnolo, F.; Guadagno, A.; Tanda, E. T.; Giusti, F.; Murdaca, G.; Queirolo, P.
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients
2019-01-01 Dalmasso, Bruna; Pastorino, Lorenza; Ciccarese, Giulia; Andreotti, Virginia; Grillo, Federica; Mastracci, Luca; Spagnolo, Francesco; Ballestrero, Alberto; Queirolo, Paola; Bruno, William; Ghiorzo, Paola
Cerivastatin Synergizes with Trametinib and Enhances Its Efficacy in the Therapy of Uveal Melanoma
2023-01-01 Amaro, Adriana Agnese; Gangemi, Rosaria; Emionite, Laura; Castagnola, Patrizio; Filaci, Gilberto; Jager, Martine J; Tanda, Enrica Teresa; Spagnolo, Francesco; Mascherini, Matteo; Pfeffer, Ulrich; Croce, Michela
Characteristics of Real-World Patients with High-Risk BRAFV600E/K-Mutated Melanoma Receiving Adjuvant Treatment with Dabrafenib Plus Trametinib After Surgical Resection, Through the Italian Managed Access Program
2023-01-01 Quaglino, P.; Ascierto, P. A.; Consoli, F.; Queirolo, P.; Spagnolo, F.; Morelli, M. F.; Berardi, R.; Chiarion-Sileni, V.; Tucci, M.; Troiani, T.; Melotti, B.; Rossi, E.; Mandala, M.; Rinaldi, G.; Marcon, I. G.; Pizzuti, M.; Del Vecchio, M.
Circulating tumor DNA-based assessment of molecular residual disease in non-metastatic melanoma
2024-01-01 De Simoni, E.; Spagnolo, F.; Gandini, S.; Gaeta, A.; Rizzetto, G.; Molinelli, E.; Simonetti, O.; Offidani, A.; Queirolo, P.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Activity and safety of first-line treatments for advanced melanoma: A network meta-analysis | 1-gen-2023 | Boutros, Andrea; Tanda, Enrica Teresa; Croce, Elena; Catalano, Fabio; Ceppi, Marcello; Bruzzone, Marco; Cecchi, Federica; Arecco, Luca; Fraguglia, Matteo; Pronzato, Paolo; Genova, Carlo; Del Mastro, Lucia; Lambertini, Matteo; Spagnolo, Francesco | |
| ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion | 1-gen-2014 | Gangemi, R; Amaro, A; Gino, A; Barisione, G; Fabbi, M; Pfeffer, U; Brizzolara, A; Queirolo, P; Salvi, S; Boccardo, S; Gualco, M; Spagnolo, F; Jager, Mj; Mosci, C; Rossello, A; Ferrini, S | |
| Adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma: Health-related quality of life from the randomized phase 3 KEYNOTE-716 study | 1-gen-2022 | Khattak, M. A.; Luke, J. J.; Long, G. V.; Ascierto, P. A.; Rutkowski, P.; Schadendorf, D.; Robert, C.; Grob, J. -J.; de la Cruz Merino, L.; Del Vecchio, M.; Spagnolo, F.; Mackiewicz, J.; Chiarion-Sileni, V.; Carlino, M. S.; Mohr, P.; De Galitiis, F.; Ross, M. I.; Eroglu, Z.; Chen, K.; Jiang, R.; Fukunaga-Kalabis, M.; Krepler, C.; Eggermont, A. M. M.; Kirkwood, J. M. | |
| Anastrozole-Induced Carpal Tunnel Syndrome: Results From the International Breast Cancer Intervention Study II Prevention Trial | 1-gen-2016 | Spagnolo, F; Sestak, I; Howell, A; Forbes, Jf; Cuzick, J | |
| Association between PD-1 single nucleotide gene variants and the risk of metastatic melanoma | 1-gen-2024 | Boutros, A.; Carosio, R.; Campanella, D.; Banelli, B.; Morabito, A.; Pistillo, M. P.; Croce, E.; Queirolo, P.; Tanda, E. T.; Raposio, E.; Fontana, V.; Spagnolo, F. | |
| Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study | 1-gen-2017 | Queirolo, P.; Dozin, B.; Morabito, A.; Banelli, B.; Piccioli, P.; Fava, C.; Leo, C.; Carosio, R.; Laurent, S.; Fontana, V.; Ferrucci, P. F.; Martinoli, C.; Cocorocchio, E.; Battaglia, A.; Ascierto, P. A.; Capone, M.; Simeone, E.; De Galitiis, F.; Pagani, E.; Cappellini, G. C. A.; Marchetti, P.; Guida, M.; Tommasi, S.; Mandala, M.; Merelli, B.; Quaglino, P.; Fava, P.; Guidoboni, M.; Romani, M.; Spagnolo, F.; Pistillo, M. P. | |
| Association of vacuum-assisted closure and platelet gel for the definitive surgical repair of an enterocutaneous fistula: a case report. | 1-gen-2012 | Scala, M; Spagnolo, F; Trapasso, Maria; Strada, P; Moresco, Luciano; Santi, Pierluigi | |
| Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma | 1-gen-2022 | Pastorino, Lorenza; Dalmasso, Bruna; Allavena, Eleonora; Vanni, Irene; Ugolini, Filippo; Baroni, Gianna; Croce, Michela; Guadagno, Antonio; Cabiddu, Francesco; Andreotti, Virginia; Bruno, William; Zoppoli, Gabriele; Ferrando, Lorenzo; Tanda, ENRICA TERESA; Spagnolo, Francesco; Menin, Chiara; Gangemi, Rosaria; Massi, Daniela; Ghiorzo, Paola | |
| Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study | 1-gen-2023 | Dummer, R.; Queirolo, P.; Gerard Duhard, P.; Hu, Y.; Wang, D.; de Azevedo, S. J.; Robert, C.; Ascierto, P. A.; Chiarion-Sileni, V.; Pronzato, P.; Spagnolo, F.; Mujika Eizmendi, K.; Liszkay, G.; de la Cruz Merino, L.; Tawbi, H. | |
| Atypical responses in patients with advanced melanoma, lung cancer, renal-cell carcinoma and other solid tumors treated with anti-PD-1 drugs: A systematic review | 1-gen-2017 | Queirolo, P.; Spagnolo, F. | |
| Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma | 1-gen-2022 | Guida, M.; Bartolomeo, N.; Quaresmini, D.; Quaglino, P.; Madonna, G.; Pigozzo, J.; Di Giacomo, A. M.; Minisini, A. M.; Tucci, M.; Spagnolo, F.; Occelli, M.; Ridolfi, L.; Queirolo, P.; De Risi, I.; Valente, M.; Sciacovelli, A. M.; Chiarion Sileni, V.; Ascierto, P. A.; Stigliano, L.; Strippoli, S. | |
| Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab | 1-gen-2016 | Ferrucci, Pf; Ascierto, Pa; Pigozzo, J; Del Vecchio, M; Maio, M; Cappellini, Gca; Guidoboni, M; Queirolo, P; Savoia, P; Mandala, M; Simeone, E; Valpione, S; Altomonte, M; Spagnolo, F; Cocorocchio, E; Gandini, S; Giannarelli, D; Martinoli, C | |
| Binimetinib for the treatment of NRAS-mutant melanoma | 1-gen-2017 | Queirolo, P.; Spagnolo, F. | |
| BRAF plus MEK-targeted drugs: a new standard of treatment for BRAF-mutant advanced melanoma | 1-gen-2017 | Queirolo, P; Spagnolo, F | |
| BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies. | 1-gen-2015 | Spagnolo, Francesco; Ghiorzo, Paola; Orgiano, L; Pastorino, Lorenza; Picasso, V; Tornari, Elena; Ottaviano, V; Queirolo, P. | |
| Case Report: Immune-Related Toxicity During Adjuvant Treatment With BRAF Plus MEK Inhibitors in a Melanoma Patient | 1-gen-2020 | Boutros, A.; Schiavi, C.; Cecchi, F.; Spagnolo, F.; Guadagno, A.; Tanda, E. T.; Giusti, F.; Murdaca, G.; Queirolo, P. | |
| CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients | 1-gen-2019 | Dalmasso, Bruna; Pastorino, Lorenza; Ciccarese, Giulia; Andreotti, Virginia; Grillo, Federica; Mastracci, Luca; Spagnolo, Francesco; Ballestrero, Alberto; Queirolo, Paola; Bruno, William; Ghiorzo, Paola | |
| Cerivastatin Synergizes with Trametinib and Enhances Its Efficacy in the Therapy of Uveal Melanoma | 1-gen-2023 | Amaro, Adriana Agnese; Gangemi, Rosaria; Emionite, Laura; Castagnola, Patrizio; Filaci, Gilberto; Jager, Martine J; Tanda, Enrica Teresa; Spagnolo, Francesco; Mascherini, Matteo; Pfeffer, Ulrich; Croce, Michela | |
| Characteristics of Real-World Patients with High-Risk BRAFV600E/K-Mutated Melanoma Receiving Adjuvant Treatment with Dabrafenib Plus Trametinib After Surgical Resection, Through the Italian Managed Access Program | 1-gen-2023 | Quaglino, P.; Ascierto, P. A.; Consoli, F.; Queirolo, P.; Spagnolo, F.; Morelli, M. F.; Berardi, R.; Chiarion-Sileni, V.; Tucci, M.; Troiani, T.; Melotti, B.; Rossi, E.; Mandala, M.; Rinaldi, G.; Marcon, I. G.; Pizzuti, M.; Del Vecchio, M. | |
| Circulating tumor DNA-based assessment of molecular residual disease in non-metastatic melanoma | 1-gen-2024 | De Simoni, E.; Spagnolo, F.; Gandini, S.; Gaeta, A.; Rizzetto, G.; Molinelli, E.; Simonetti, O.; Offidani, A.; Queirolo, P. |